Consenso sobre guías de tratamiento de los glioblastomas elaborado por el Grupo de Trabajo de Neurooncología (GTNO) de la SENEC
- 18 July 2020
- journal article
- research article
- Published by Elsevier BV in Neurocirugia
- Vol. 31 (6), 289-298
- https://doi.org/10.1016/j.neucir.2020.06.001
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Impact of extent of resection for recurrent glioblastoma on overall survivalJournal of Neurosurgery, 2012
- Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trialThe Lancet Oncology, 2012
- Scale to Predict Survival After Surgery for Recurrent Glioblastoma MultiformeJournal of Clinical Oncology, 2010
- Supratentorial Glioblastoma Multiforme: The Role of Surgical Resection Versus Biopsy Among Older PatientsAnnals of Surgical Oncology, 2010
- Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide scheduleCancer, 2008
- Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trialThe Lancet Oncology, 2006
- Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trialActa Neurochirurgica, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaThe New England Journal of Medicine, 2005
- Debulking or biopsy of malignant glioma in elderly people – a randomised studyActa Neurochirurgica, 2003
- Development of a Fluorescein Operative Microscope for use During Malignant Glioma Surgery: A Technical Note and Preliminary ReportSurgical Neurology, 1998